References
- Chen HZ, Ding BP, Zhang NB, Chen L, Huang HZ. 2010. Extraction of rhomotoxin and its LD50. Chin Pharm. 19(15):10–11.
- Chen QQ, Fang X, Xue QW, He YC, Liang S. 2020. Study on the quality of different officinal parts of Rhododendron Molle G. Don based on content determination of Rhododendron-III and Rhododendron-IV by HPLC. Acad J Shanghai Univ Tradit Chin Med. 34(6):77–82.
- Chen G, Jin HZ, Li XF, Zhang Q, Yan SK, Shen YH, Zhang WD. 2008. The chemical and pharmacological progress of the plant in Rhododendron family. J Pharm Prac. 26(4): 255–257.
- Chinese Medicine Dictionary Volume I. 1986. Nao Yang Hua. Shanghai: Shanghai Science and Technology Press; p. 973.
- Hikino H, Ito K, Ota T, Takemoto T. 1969. Stereostructure of rhodojaponin I, II, and 3, toxins of Rhododendron japonicum, and of asebotoxin 3, toxin of Pieris japonica. Chem Pharm Bull (Tokyo). 17(5):1078–1079.
- He YC, Yao YM, Xue QW, Fang X, Liang S. 2021. Anti-rheumatoid arthritis potential of diterpenoid fraction derived from Rhododendron molle fruits. Chin J Nat Med. 19(3):181–187.
- Yao M, Dai WY, Jing LY, He ML, Tun RL, Gao WQ, Bao YM. 2011. Animal experimental study of detoxication effect in Fructus Gardeniae to acute toxicity of Flos Rhododendri Mollis. Lishizhen Med Mater Med Res. 20(11):1777–1779.
- Yao YM, Fang X, Li J, Zhang JQ, Ruan KF, Liang S. 2019. Study on anti-inflammatory effects of diterpenoids and different polarity fractions from Rhododendron molle G. Don in vivo and in vitro. Aca Univ Tradit Med Chinese Sin Pharmacol Shanghai. 33(4):84–88.
- Zhu RF. Hu Fd 2011. Orthogonal test for optimization of flavoneextraction technology from Rhododendron Molle. J Hefei Univ (Nat Sci). 21(3):78–80.
- Zou HY, Luo J, Xu DR, Kong LY. 2014. Tandem solid-phase extraction followed by HPLC-ESI/QTOF/MS/MS for rapid screening and structural identification of trace diterpenoids in flowers of Rhododendron molle. Phytochem Anal. 25(3):255–265.